Pharmacokinetic Evidence for Suboptimal Treatment of Adrenal Insufficiency with Currently Available Hydrocortisone Tablets, Clinical Pharmacokinetics, vol.83, issue.7, pp.455-63, 2010. ,
DOI : 10.7326/0003-4819-141-10-200411160-00007
URL : https://hal.archives-ouvertes.fr/hal-00625323
Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey, BMC Endocrine Disorders, vol.95, issue.1, p.8, 2012. ,
DOI : 10.1210/jc.2010-0917
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.2, pp.364-89, 2016. ,
DOI : 10.1210/jc.2015-1710
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency, Journal of Internal Medicine, vol.92, issue.2, pp.104-119, 2014. ,
DOI : 10.1172/JCI116843
The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients, European Journal of Endocrinology, vol.97, issue.2, pp.571-580, 2014. ,
DOI : 10.1210/jc.2011-1901
Addison's disease: a survey on 633 patients in Padova, European Journal of Endocrinology, vol.499, issue.2, pp.773-84, 2013. ,
DOI : 10.1016/j.gene.2012.03.032
Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Journal of Endocrinology, vol.169, issue.1, pp.65-70, 2001. ,
DOI : 10.1677/joe.0.1690065
The Production Rate of Cortisol in Man, BMJ, vol.1, issue.5078, pp.1020-1024, 1958. ,
DOI : 10.1136/bmj.1.5078.1020
Daily Cortisol Production Rate in Man Determined by Stable Isotope Dilution/Mass Spectrometry, The Journal of Clinical Endocrinology & Metabolism, vol.72, issue.1, pp.39-45, 1991. ,
DOI : 10.1210/jcem-72-1-39
Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis, J Clin Endocrinol Metab, vol.77, pp.458-63, 1993. ,
Adrenal insufficiency, The Lancet, vol.361, issue.9372, pp.1881-93, 2003. ,
DOI : 10.1016/S0140-6736(03)13492-7
Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency, Clinical Endocrinology, vol.38, issue.3, pp.367-75, 2004. ,
DOI : 10.1016/S0140-6736(00)04006-X
Premature mortality due to cardiovascular disease in hypopituitarism, The Lancet, vol.336, issue.8710, pp.285-293, 1990. ,
DOI : 10.1016/0140-6736(90)91812-O
Morbidity in patients on long-term steroid replacement therapy, Clinical Endocrinology, vol.141, issue.4, pp.564-570, 2010. ,
DOI : 10.1111/j.1365-2265.2009.03656.x
Premature Mortality in Patients with Addison???s Disease: A Population-Based Study, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.12, pp.4849-53, 2006. ,
DOI : 10.1210/jc.2006-0076
Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.10, pp.1938-1980, 2012. ,
DOI : 10.1210/jc.2012-2432
URL : https://academic.oup.com/jcem/article-pdf/97/10/E1938/10782240/jcem1938.pdf
The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.10, pp.3954-61, 2006. ,
DOI : 10.1210/jc.2006-0524
Optimization of glucocorticoid replacement therapy: the long-term effect on bone mineral density, Clinical Endocrinology, vol.120, issue.6, pp.815-822, 1999. ,
DOI : 10.7326/0003-4819-120-3-199402010-00005
Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency, European Journal of Endocrinology, vol.75, issue.4, pp.531-539, 2016. ,
DOI : 10.1111/j.1365-2265.2011.04074.x
Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients, European Journal of Endocrinology, vol.80, issue.10, pp.141-50, 2014. ,
DOI : 10.1210/jc.80.10.2859
Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency, Clinical Endocrinology, vol.371, issue.Spec No, pp.297-304, 2010. ,
DOI : 10.1007/BF03345252
Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.10, pp.3912-3934, 2007. ,
DOI : 10.1210/jc.2007-0685
The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency ??? Results from a randomized controlled trial, Psychoneuroendocrinology, vol.55, pp.36-47, 2015. ,
DOI : 10.1016/j.psyneuen.2015.02.001
Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency, European Journal of Endocrinology, vol.96, issue.4, pp.679-85, 2012. ,
DOI : 10.1210/jc.2010-2490
Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters, Journal of Endocrinological Investigation, vol.46, issue.Suppl.4, pp.449-54, 2004. ,
DOI : 10.1046/j.1365-2265.1997.87897.x
The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol, Clinical Endocrinology, vol.20, issue.5, pp.632-637, 2007. ,
DOI : 10.1016/0026-0495(88)90164-3
Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency, Diabetes Care, vol.36, issue.1, p.8, 2013. ,
DOI : 10.2337/dc12-1499
Cortisol production rate in childhood and adolescence, The Journal of Pediatrics, vol.117, issue.6, pp.892-898, 1990. ,
DOI : 10.1016/S0022-3476(05)80128-3
Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood, PEDIATRICS, vol.119, issue.2, pp.484-94, 2007. ,
DOI : 10.1542/peds.2006-1612
Hydrocortisone Dosing during Puberty in Patients with Classical Congenital Adrenal Hyperplasia: An Evidence-Based Recommendation, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.10, pp.3882-3890, 2009. ,
DOI : 10.1210/jc.2009-0942
Glucocorticoid regulation of the circadian clock modulates glucose homeostasis, Proceedings of the National Academy of Sciences, vol.197, issue.1, pp.17582-17589, 2009. ,
DOI : 10.1677/JOE-07-0606
A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency, Clinical Endocrinology, vol.161, issue.Suppl 1, pp.18-25, 2012. ,
DOI : 10.1530/EJE-09-0170
Impaired health-related quality of life in Addison's disease - impact of replacement therapy, comorbidities and socio-economic factors, Clinical Endocrinology, vol.95, issue.4, pp.511-519, 2014. ,
DOI : 10.1210/jc.2009-1711
Continuous subcutaneous hydrocortisone infusion in Addison's disease, European Journal of Endocrinology, vol.157, issue.1, pp.109-121, 2007. ,
DOI : 10.1530/EJE-07-0052
Continuous Subcutaneous Hydrocortisone Infusion Therapy in Addison's Disease: A Randomized, Placebo-Controlled Clinical Trial, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.11, pp.4149-57, 2014. ,
DOI : 10.1210/jc.2014-2433
Continuous Subcutaneous Hydrocortisone Infusion versus Oral Hydrocortisone Replacement for Treatment of Addison's Disease: A Randomized Clinical Trial, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.5, pp.1665-74, 2014. ,
DOI : 10.1210/jc.2013-4253
Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study, European Journal of Endocrinology, vol.161, issue.1, pp.119-149, 2009. ,
DOI : 10.1530/EJE-09-0170
Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency, European Journal of Endocrinology, vol.339, issue.6, pp.619-645, 2015. ,
DOI : 10.1097/MAJ.0b013e3181db6b7a
Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.2, pp.473-81, 2012. ,
DOI : 10.1210/jc.2011-1926
Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers, Clinical Endocrinology, vol.144, issue.1, pp.130-135, 2008. ,
DOI : 10.1002/j.1552-4604.1996.tb04206.x
Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia., Archives of Disease in Childhood, vol.56, issue.3, pp.208-221, 1981. ,
DOI : 10.1136/adc.56.3.208
Continuous subcutaneous hydrocortisone infusion (CSHI) in a young adolescent with congenital adrenal hyperplasia (CAH), Journal of Pediatric Endocrinology and Metabolism, vol.2, issue.7-8, pp.561-564, 2011. ,
DOI : 10.1136/adc.85.1.26
The child with difficult to control Congenital Adrenal Hyperplasia: is there a place for continuous subcutaneous hydrocortisone therapy, Clinical Endocrinology, vol.86, issue.1, pp.15-23, 2014. ,
DOI : 10.1136/adc.86.4.266
Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison???s disease, Endocrine, vol.77, issue.Suppl 1, pp.360-368, 2016. ,
DOI : 10.1111/j.1365-2265.2012.04352.x
Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements, Clinical Endocrinology, vol.5, issue.0, pp.384-393, 2006. ,
DOI : 10.1111/j.1365-2265.1976.tb03801.x
Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys?? Cortisol II assay, Annales d'Endocrinologie, vol.77, issue.5, pp.620-622, 2016. ,
DOI : 10.1016/j.ando.2016.05.002
Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay, Clinical Biochemistry, vol.50, issue.9, pp.475-80, 2017. ,
DOI : 10.1016/j.clinbiochem.2017.02.008
Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy, European Journal of Endocrinology, vol.157, issue.1, pp.719-748, 2009. ,
DOI : 10.1530/EJE-07-0052
Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency, PLOS ONE, vol.97, issue.Suppl 5, p.135975, 2015. ,
DOI : 10.1371/journal.pone.0135975.s001
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency, European Journal of Endocrinology, vol.93, issue.5, pp.769-76, 2012. ,
DOI : 10.1210/jc.2008-0125
Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to Patients with adrenal insufficiency, Clinical Endocrinology, vol.64, issue.6, pp.789-96, 2007. ,
DOI : 10.1515/CCLM.2004.264
Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy, Clinical Endocrinology, vol.58, issue.6, pp.687-93, 2011. ,
DOI : 10.1016/S0379-0738(99)00179-6
Intrinsic imperfections of endocrine replacement therapy, European Journal of Endocrinology, vol.149, issue.2, pp.91-98, 2003. ,
DOI : 10.1530/eje.0.1490091
Serum Cortisol and 17-Hydroxyprogesterone Interrelation in Classic 21-Hydroxylase Deficiency: Is Current Replacement Therapy Satisfactory?, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.10, pp.4679-85, 2001. ,
DOI : 10.1210/jcem.86.10.7972
Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia, Clinical Endocrinology, vol.100, issue.4, pp.522-529, 2016. ,
DOI : 10.1210/jc.2014-4328
DIURNAL SALIVARY CORTISOL PATTERNS DURING PREGNANCY AND AFTER DELIVERY: RELATIONSHIP TO PLASMA CORTICOTROPHIN-RELEASING-HORMONE, Clinical Endocrinology, vol.62, issue.2, pp.279-89, 1990. ,
DOI : 10.1016/0006-291X(83)91192-0
The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment, Endocrine Reviews, vol.26, issue.6, pp.775-99, 2005. ,
DOI : 10.1210/er.2004-0025
Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone, J Clin Endocrinol Metab, vol.75, pp.259-64, 1992. ,
EVIDENCE THAT PATIENTS WITH ADDISON'S DISEASE ARE UNDERTREATED WITH FLUDROCORTISONE, The Lancet, vol.323, issue.8367, pp.11-15, 1984. ,
DOI : 10.1016/S0140-6736(84)90181-8
Mineralocorticoids in the management of primary adrenocortical insufficiency, Journal of Endocrinological Investigation, vol.293, issue.2, pp.87-91, 1991. ,
DOI : 10.1136/bmj.293.6550.808
Cardiac failure in Addison's disease, The American Journal of Medicine, vol.74, issue.5, pp.829-865, 1983. ,
DOI : 10.1016/0002-9343(83)91074-4
THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe, European Journal of Endocrinology, vol.45, issue.9608, pp.165-75, 2013. ,
DOI : 10.1016/S0140-6736(08)60132-4
The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man., Journal of Clinical Investigation, vol.58, issue.1, pp.221-230, 1976. ,
DOI : 10.1172/JCI108453
The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency, Clin Endocrinol, vol.45, pp.529-563, 1996. ,
Effect of administered mineralocorticoids or ACTH in pregnant women, Journal of Clinical Investigation, vol.51, issue.6, pp.1301-1310, 1972. ,
DOI : 10.1172/JCI106926
What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?, Clinical Endocrinology, vol.75, issue.4, pp.497-502, 2013. ,
DOI : 10.1210/jc.75.1.259
Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease, European Journal of Endocrinology, vol.54, issue.4, pp.761-770, 2011. ,
DOI : 10.1016/S0895-4356(00)00314-0
Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency, American Journal of Hypertension, vol.17, issue.2, pp.266-72, 2016. ,
DOI : 10.1111/cen.12498
Subjective health status in Norwegian patients with Addison's disease*, Clinical Endocrinology, vol.30, issue.5, pp.581-589, 2002. ,
DOI : 10.1046/j.1365-2265.1999.00723.x
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency, New England Journal of Medicine, vol.341, issue.14, pp.1013-1033, 1999. ,
DOI : 10.1056/NEJM199909303411401
Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.2, pp.400-409, 2008. ,
DOI : 10.1210/jc.2007-1134
Effect of Dehydroepiandrosterone Replacement on Lipoprotein Profile in Hypoadrenal Women, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.3, pp.761-765, 2009. ,
DOI : 10.1210/jc.2008-1774
Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.5, pp.2046-52, 2002. ,
DOI : 10.1210/jcem.87.5.8494
A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials of DHEA Treatment Effects on Quality of Life in Women with Adrenal Insufficiency, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.10, pp.3676-81, 2009. ,
DOI : 10.1210/jc.2009-0672
Dehydroepiandrosterone Improves Psychological Well-Being in Male and Female Hypopituitary Patients on Maintenance Growth Hormone Replacement, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.10, pp.3773-3782, 2006. ,
DOI : 10.1210/jc.2006-0316